Loading clinical trials...
Loading clinical trials...
To assess the effectiveness of interventions including health monitoring and regular return follow-up reminders for patients with a high Composite Immune Risk Score.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Institute of Hematology & Blood Diseases Hospital, China
NCT07013370 · Immunoglobulin Prophylaxis, Cytomegalovirus Infections, and more
NCT06950788 · Cirrhosis, Liver, Diabetes Mellitus Risk, and more
NCT05599256 · Transplant-Related Disorder
NCT05798286 · Lung Diseases, Transplant-Related Disorder
NCT03636412 · Transplant-Related Disorder, Frail Elderly Syndrome, and more
Institute of Hematology & Blood Diseases Hospital
Tianjin, Tianjin Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions